Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,133

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

for

B-cell Malignancy, Chronic Lymphocytic Leukemia,

Location: Houston TX, Tampa FL, Chicago IL, Fort Wayne IN,

Sponsor: Carna Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05602363

Phase 1, Recruiting

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

for

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma,

Location: Houston TX, Nashville TN, Tampa FL, Ann Arbor MI,

Sponsor: Remix Therapeutics

Sex: All

Age: 18+

Code: NCT06118086

Phase 1, Phase 2, Recruiting

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

for

Psychosis

Location: Houston TX

Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT06194344

Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for

Colorectal Neoplasms

Location: Houston TX, Round Rock TX, Temple TX, San Antonio TX,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

for

Ovarian Cancer

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT06545604

Recruiting

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion

for

Advanced Cholangiocarcinoma, FGFR2 Fusion

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06439485

Phase 1, Phase 2, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for

Tophaceous Gout

Location: Houston TX, Sugar Land TX, Katy TX, Tomball TX,

Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase 3, Recruiting

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for

NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC,

Location: Houston TX, Tampa FL, Columbus OH, Grand Rapids MI,

Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07085091

Phase 1, Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for

Platinum-resistant Ovarian Cancer,

Location: Houston TX, San Antonio TX, New Orleans LA, Madison WI,

Sponsor: MacroGenics

Sex: Female

Age: 18+

Code: NCT06730347

Phase 2, Recruiting

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

for

Thyroid Gland Medullary Carcinoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03892993

Recruiting

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

for

Ivonescimab, Clear Cell Renal Carcinoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06940518

Phase 2, Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma,

Location: Houston TX, Aurora CO, Chicago IL, Scottsdale AZ,

Sponsor: SciTech Development, Inc.

Sex: All

Age: 18+

Code: NCT04234048

Phase 1, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for

Breast Neoplasms, Triple Negative Breast Neoplasms,

Location: Houston TX, San Antonio TX, Shreveport LA, Dallas TX,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase 3, Recruiting

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for

Advanced Solid Tumor

Location: Houston TX, Madison WI, Fairfax VA, Hackensack NJ

Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06598800

Phase 1, Recruiting

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

for

Myelodysplastic Syndromes

Location: Houston TX, Goodyear AZ, Canton OH, Irvine CA,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06847867

Phase 2, Recruiting

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

for

Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases,

Location: Houston TX, Dallas TX, Brentwood TN, Orlando FL,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06858319

Phase 3, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for

Melanoma, Cutaneous Malignant, Mucosal Melanoma

Location: Houston TX, Dallas TX, Nashville TN, Atlanta GA,

Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for

Metastatic Colorectal Cancer

Location: Houston TX, Grand Rapids MI, Cleveland OH, New Haven CT

Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07079631

Phase 1, Phase 2, Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

for

Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,

Location: Houston TX, Dallas TX, Lexington KY, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05691465

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for

B Acute Lymphoblastic Leukemia

Location: Houston TX, Austin TX, Temple TX, Corpus Christi TX,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City

Paid Clinical Trials Houston

Filter results

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

Interested in new trials?

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)